“Early-stage hodgkin lymphoma in the modern era: simulation modeling to delineate long-term patient outcomes.”

Parsons SK, Kelly MJ, Cohen JT, Catellino SM, Henderson TO, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM.

British J Haematol. 2018 Jul;182(2):212-221. PMID 29707774. PMCID PMC6055753.

“Health-related quality of life in Hodgkin lymphoma: a systematic review.”

Linendoll N, Saunders T, Burns R, Nyce JD, Wendell KB, Evens AM, Parsons SK

Health Qual Life Outcomes. 2016 Jul 29;14(1):114. PMID: 27473596. PMCID: PMC4966803.

“Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review.”

Fu J, Upshaw J, Cohen J, Rodday AM, Saunders T, Kelly M, Evens AM, Parsons SK.

Leuk Lymphoma. 2018 Aug;59(8):1976-1980. PMID: 29214876.

“Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.”

Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM.

Cancer. 2018 Jan 1;124(1):136-144. PMID: 28902390. PMCID: PMC5735034.

“First-line Treatment in Older Patients With Hodgkin Lymphoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Population-Based Study.”

Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK.

British J Haematol. 2020 Feb 23. doi: 10.1111/bjh.16525. Online ahead of print.  PMID: 32090325